These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 1411865)

  • 61. [Effect of recombinant human erythropoietin on hemodynamics in chronic hemodialysis patients].
    Tomura S
    Nihon Rinsho; 1991 Dec; 49 Suppl():695-701. PubMed ID: 1808338
    [No Abstract]   [Full Text] [Related]  

  • 62. [The use of recombinant erythropoietin with patients on programmed hemodialysis].
    Rozental' RL; Zezina LIu; Spudass AV
    Ter Arkh; 1991; 63(12):110-3. PubMed ID: 1803587
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Results of treating uremia anemia with human recombinant erythropoietin].
    Litwin M; Grenda R; Jelonek A
    Pol Tyg Lek; 1994 Feb 7-14; 49(6-7):132-4. PubMed ID: 8090664
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Correction of anaemia in haemodialysis patients with recombinant human erythropoietin.
    Boran M; Dalva I; Yazicioğlu A; Akbay E; Cetin S
    Int Urol Nephrol; 1993; 25(2):197-203. PubMed ID: 8365853
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Recombinant human erythropoietin reduces free erythrocyte protoporphyrin levels in patients on chronic dialysis.
    Piazza V; Villa G; Galli F; Segagni S; Bovio G; Poggio F; Picardi L; Salvadeo A
    Nephron; 1992; 61(1):54-7. PubMed ID: 1528341
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin.
    Eschbach JW; Kelly MR; Haley NR; Abels RI; Adamson JW
    N Engl J Med; 1989 Jul; 321(3):158-63. PubMed ID: 2747747
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Vascular changes in hemodialysis patients in response to recombinant human erythropoietin.
    London GM; Zins B; Pannier B; Naret C; Berthelot JM; Jacquot C; Safar M; Drueke TB
    Kidney Int; 1989 Nov; 36(5):878-82. PubMed ID: 2615194
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Reduced glutathione for the treatment of anemia during hemodialysis: a preliminary communication.
    Zachée P; Ferrant A; Daelemans R; Goossens W; Boogaerts MA; Lins RL
    Nephron; 1995; 71(3):343-9. PubMed ID: 8569984
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Treatment of anemia in patients on a regular dialysis program using human recombinant erythropoietin].
    Sulková S; Kvasnicka J; Kasl M; Kozlová J; Podrouzek P; Bartůnková J; Válek A
    Cas Lek Cesk; 1989 Sep; 128(40):1257-60. PubMed ID: 2582471
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Recombinant human erythropoietin treatment of anemic cancer patients.
    Henry DH
    Cancer Pract; 1996; 4(4):180-4. PubMed ID: 8900758
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Recombinant human erythropoietin (rh-EPO) in chronic, dialysis-dependent renal failure: effects on macro- and microcirculation and hematologic parameters].
    Köhler M; Mörsdorf S; Jung F; Braun B; Waldhausen P; Pindur G; Weber U; Bosslet R; Bambauer R; Jutzler GA
    Beitr Infusionsther; 1990; 26():89-95. PubMed ID: 1703909
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Changes in the alpha adrenergic system and increase in blood pressure with recombinant human erythropoietin (rHuEpo) therapy for renal anemia.
    Müller R; Steffen HM; Brunner R; Saric J; Pollok M; Baldamus CA; Kaufmann W
    Clin Invest Med; 1991 Dec; 14(6):614-22. PubMed ID: 1665406
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Expression of fibrinogen receptors and GPIIb molecules on uraemic platelets: effect of recombinant human erythropoietin therapy.
    Krzesłowska J; Rysz J; Cierniewski CS; Luciak M
    Nephrol Dial Transplant; 1995; 10(5):653-6. PubMed ID: 7566578
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Variability of the response to recombinant human erythropoietin in patients undergoing hemodialysis treatment].
    Baroni A; Airoldi G; Agliata S; Fortina F; Ragazzoni E; Cavagnino A; De Nigris A; Cametti G; Ferrero D; Fortina A
    Minerva Urol Nefrol; 1991; 43(3):131-5. PubMed ID: 1817334
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Erythropoietin and hypertension].
    Frei U; Nonnast-Daniel B; Koch KM
    Klin Wochenschr; 1988 Sep; 66(18):914-9. PubMed ID: 3054276
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A pharmacodynamic model of erythropoietin therapy for uremic anemia.
    Uehlinger DE; Gotch FA; Sheiner LB
    Clin Pharmacol Ther; 1992 Jan; 51(1):76-89. PubMed ID: 1732079
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Variations of recombinant human erythropoietin application in hemodialysis patients.
    Bommer J; Samtleben W; Koch KM; Baldamus CA; Grützmacher P; Scigalla P
    Contrib Nephrol; 1989; 76():149-56; discussion 156-8. PubMed ID: 2684517
    [No Abstract]   [Full Text] [Related]  

  • 78. Use of erythropoietin in ischemic and arrhythmic cardiopathy of hemodialyzed patients.
    Bellinghieri G; Savica V; De Gregorio C; De Gregorio G
    Contrib Nephrol; 1994; 106():135-7. PubMed ID: 8174359
    [No Abstract]   [Full Text] [Related]  

  • 79. Anemia of hemodialysis patients: evaluation of the effect of BK-F polymethylmethacrylate membrane.
    Locatelli F; Andrulli S; Del Vecchio L
    Contrib Nephrol; 1999; 125():173-81. PubMed ID: 9895439
    [No Abstract]   [Full Text] [Related]  

  • 80. The influence of buflomedil on blood viscosity parameters in insulin-dependent diabetic patients: a preliminary study.
    Van Acker K; Rillaerts E; De Leeuw I
    Biomed Pharmacother; 1989; 43(3):219-22. PubMed ID: 2775859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.